Therapeutic Potential of Implanted Tissue‐Engineered Bioartificial Muscles Delivering Recombinant Proteins to the Sheep Heart
- 1 June 2002
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 961 (1) , 78-82
- https://doi.org/10.1111/j.1749-6632.2002.tb03055.x
Abstract
Abstract: Tissue‐engineered primary adult sheep muscle cells genetically engineered to express either rhVEGF or rhIGF‐1 secreted the bioactive proteins locally in the sheep heart for at least 30 days.Keywords
This publication has 3 references indexed in Scilit:
- Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis.Circulation, 2001
- Gene Transfer for Angiogenesis in Coronary Artery DiseaseAnnual Review of Medicine, 2001
- Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failureAmerican Heart Journal, 1999